Integra Lifesciences recently received an FDA warning letter pertaining to quality systems issues at several facilities. The company announced in an SEC filing that it received the warning letter on December 19, 2024, that outlined issues identified during FDA inspections at three of its facilities in Mansfield, Massachusetts, Plainsboro, New Jersey, and Princeton, New Jersey. […]
Integra LifeSciences
Integra Lifesciences appoints Mojdeh Poul as CEO
Integra Lifesciences today announced it named Mojdeh Poul as president and CEO, effective January 6, 2025. Poul will also join the Integra board when she assumes her new role at the New Jersey–based tissue regeneration and neurological treatment technology companies in January. She succeeds Jan De Witte, who will remain president and CEO until January […]
Integra Lifesciences appoints new chief quality officer
Integra Lifesciences today announced it appointed Linette Torres as chief quality officer. Torres joins the company after more than two decades at Edwards Lifesciences, where she was most recently senior vice president of critical care quality. “Linnette is a seasoned senior leader with extensive global experience in quality and operations and a record of accomplishments […]
Integra LifeSciences to restart tissue tech manufacturing in Massachusetts
Integra LifeSciences announced today that it plans to restart the manufacturing of two products at a new facility in Massachusetts. The company plans to resume manufacturing for PriMatrix and SurgiMend at its new Braintree, Massachusetts, facility. Princeton, New Jersey-based Integra expects to operationalize the plant in the first half of 2026. Integra’s shift comes following […]
Integra Lifesciences terminates post-market nerve repair registry
Integra LifeSciences terminated a post-market registry evaluating the company’s NeuraGen and NeuraGen 3D nerve repair products. BTIG analyst Ryan Zimmerman flagged the registry termination, which is confirmed on ClinicalTrials.Gov. The company’s latest update came yesterday, July 11. The reason listed for termination is “slow enrollment, sponsor decision.” According to Zimmerman, Integra intended to recruit 350 […]
Integra Lifesciences posts mixed-bag Q1 results as Boston distribution facility faces another setback
Integra LifeSciences today announced first-quarter results that beat the revenue consensus on Wall Street and matched earnings estimates. The Princeton, N.J.-based company reported profit losses of $3.3 million, or -4¢ per share, on sales of $368.9 million for the three quarters ended March 31, 2024. Sales for Q1 were down slightly from the same period […]
Integra LifeSciences completes acquisition of J&J’s Acclarent
Integra LifeSciences announced that it completed its previously announced acquisition of Acclarent from Johnson & Johnson MedTech . Princeton, New Jersey-based Integra struck a deal with J&J to acquire Acclarent for $275 million upfront at the end of 2023. The deal also includes an additional $5 million upon the achievement of regulatory milestones. Acclarent, part […]
Integra LifeSciences launches MicroMatrix Flex
Integra LifeSciences today announced it launched its MicroMatrix Flex dual-syringe system for urinary bladder matrix (UBM) access. The Princeton, N.J.-based company designed MicroMatrix Flex to enable the convenient mixing and precise delivery of MicroMatrix paste to provide more convenient access to hard-to-reach spaces in wound management. “MicroMatrix Flex has allowed me to expand how I […]
Integra LifeSciences CEO Jan De Witte to retire
Integra LifeSciences announced today that President and CEO Jan De Witte informed the board of his intention to retire. De Witte plans to retire following the appointment of a successor. Integra anticipates that appointment to come by the end of 2024. Additionally, the company appointed Stuart Essig, Integra chair, to the role of executive chair, […]
Integra Lifesciences announces a plant closure
Integra Lifesciences is closing its ACell plant in Lafayette, Indiana, letting go of almost all of the workers. Princeton, New Jersey–based Integra informed the Indiana Department of Workforce Development in a Feb. 13 WARN notice that the closure will result in a layoff of 60 workers — 52 on April 26 and eight on May […]
Integra LifeSciences to buy Johnson & Johnson’s Acclarent and its ENT tech
Integra LifeSciences announced today that it entered into a definitive agreement to acquire Acclarent from Johnson & Johnson MedTech. Acclarent, part of J&J MedTech’s Ethicon unit, enhances Integra’s position in the ear, nose and throat (ENT) treatment market. Integra already offers the MicroFrance line of ENT instruments. The company believes that, upon closing, the deal […]
